Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Bruker Corp announces FDA clearance to market the MALDI biotyper CA system


Tuesday, 26 Nov 2013 07:00am EST 

Bruker Corp:Says it has been granted U.S. FDA clearance to market its MALDI BiotyperCA System in the United States for the identification of Gram negative bacterial colonies cultured from human specimens. 

Company Quote

18.47
 --
31 Mar 2015